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Abstract: Several epidemiological studies associated the consumption of wine with the reduction of
the risk factors for cardiovascular disease and certain cancers, as well as for diabetes. These conditions
are characterized by inflammatory mechanisms in addition to other biological mechanisms. Acute and
chronic inflammation is mediated by a plethora of biomarkers production and pathway activation. Since
the health promoting properties of wine in different pathological conditions may include the reduction
of inflammation, the aim of this paper was to collect and review the in vitro, in vivo, and human studies
performed to evaluate the effects of wine on different models of inflammation. Although great variability
in wine intake, period of consumption, and content of phenolic compounds was observed, data from
both human and animal studies showed a positive modulation of inflammatory biomarkers (cytokines,
coagulation parameters) and oxidative stress (mainly malondialdehyde) involved in cardiovascular
function. In addition, some convincing evidence was obtained in different models suggesting a positive
modulation of risk factors for gastric and intestinal inflammation. Contradictory results were obtained
for metabolic syndrome and type 2 diabetes. To date, no significant paper has been published in the
area of immune function. Integrating in vivo data and in vitro studies, the NF-κB pathway has been
identified as a critical target for the protective properties of a moderate wine consumption.
Keywords: wine; inflammation; in vitro methods; animal studies; human trials
1. Introduction
The interest in a positive role of wine on human health has grown since 1979, when a first
report showing an inverse association between moderate wine consumption and mortality was
published [1]. This correlation has been confirmed by epidemiological observations; in particular,
the lower cardiovascular mortality rate in France in comparison with other countries where a
similar consumption of saturated fats was reported, the so-called “French paradox” [2]. Since then,
many authors have associated the consumption of wine with a J-shaped reduction of the risk factors
for cardiovascular disease and certain cancers, as well as for diabetes and dementia [3,4]. Although
different factors are involved (age, phenotypes, dietetic habits, etc.), the observed beneficial effects of
red wine in particular, are generally associated with the moderate consumption, which could be defined
as consumption of 200–300 mL/day for men (corresponding to 20–30 g ethanol) and 100–200 mL/day
for women (10–20 g ethanol) with meals [5,6].
Most scientific studies have suggested that any positive effects of wine on human health
are associated with its phenolic compounds and ethanol, that can synergistically affect several
biochemical factors with potential cardioprotective properties, including lipid profile, platelet aggregation,
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and endothelial function. In more detail, flavonoids and their metabolites, which are the most
important phenolic fractions for human health, are generally responsible for the antioxidant and radical
scavenging activity of wine. Red wine contains flavanols (500–1500 mg/L), flavonols (50–200 mg/L),
and anthocyanins (90–400 mg/L) [7]. In addition, a non-flavonoid phenolic compound has been
extensively studied for its healthy potential: the stilbene monomer trans-resveratrol [8,9]. According
to some authors, the mechanism associated with the beneficial effects of wine could be due not only
to phenolic compounds but also to an increase of uric acid concentration in plasma, and of its related
antioxidant activity [10]. If oxidative stress is recognized as one of the main factors in promoting
different pathological conditions, an increasing body of evidence shows that several chronic diseases
are modulated by inflammation; among others: arthritis, cancer, cardiovascular diseases, diabetes,
chronic inflammatory bowel diseases (IBD), and neurological diseases [11]. The dysregulation of various
signaling pathways, such as the nuclear factor kappa-B (NF-κB) and signal transducer and activator
of transcription 3 (STAT3), seems to be involved in inflammation. In fact, these factors regulate the
transcription of specific enzymes, such as cycloxigenase-2 (COX-2), matrix metalloproteinase-9 (MMP-9),
and inflammatory cytokines (tumor necrosis factor alpha (TNF-α), interleukin-1, -6, -8, (IL-1, IL-6, IL-8),
and chemokines) [12]. The relationship between inflammation and chronic diseases has been suggested by
different papers [11,13], as well as the possible positive role of wine in this process by in vitro and in vivo
models. The results of these studies are often contradictory due to: (1) differences in the experimental
model used; (2) heterogeneous biomarkers considered, since inflammation is a complex phenomenon,
which can affect several physiological systems and pathways; (3) difficulty in selecting reliable biomarkers
to measure the positive effects; and (4) the absence of the chemical characterization of wine, where several
molecules (including alcohol) can be responsible for the increase or reduction of inflammatory biomarkers.
On the basis of the limits reported above, the aim of this paper was the collection and critical
assessment of data present in the scientific literature, where inflammation was correlated with the
intake of wine. In vitro and in vivo models as well as human trials will be considered, in order to
identify the most suitable inflammatory biomarkers, and the most useful models/methods for the
quantification of these biomarkers and their variations from moderate wine consumption.
2. Methods
The following databases were searched electronically to identify relevant articles published from
database inception up to September 2018: PubMed/Medline, Embase, Cab Abstract. The search limits
were in vitro, in vivo, clinical methodologies, and the European languages. A search strategy was
developed for each database. using specific medical subject heading (MeSH) terms (e.g., inflammation
mediators, inflammatory diseases, and wine) in addition to relevant text keywords (alcohol, wine,
methods, analytical approaches).
Titles and abstracts of collected citations were first screened to identify the suitable publications,
that is in vivo methods developed in humans or animals, and in vitro approaches used to evaluate
the effect of wine/wine extracts in inflammatory pathways. Papers reporting data on the use of pure
standard compounds, reviews, and patents were excluded.
3. Results and Discussion
The search by title and abstract retrieved 424 papers. After removal of duplicates and application
of the inclusion/exclusion criteria, the total number of papers was 27.
3.1. In Vitro Methods
Table 1 reports the in vitro methods applied to investigate the effects of wine on parameters related
to inflammation. Intestinal inflammation was the most common condition investigated, using Caco-2
and HT29 cells. Both are well characterized epithelial cell lines, derived from a primary colon tumor;
thanks to their similarities with enterocytes of the human small intestine, they are a suitable model to
study effects/absorption of food substances [12–15].
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Table 1. Selected papers describing in vitro trials describing the wine effects on inflammation.
Wine/Dosage Model Aim Biomarkers Method Outcomes Showing StatisticalSignificant Changes Ref.
Endothelial function
RW (GAE 1, 10, 50 µg/mL) HUVECHMEC
To evaluate the vascular anti-inflammatory effects
of two typical South Italy RWE (Primitivo and
Negroamaro) and the specific contribution of
each polyphenol
ICAM-1, VCAM-1 and E-Selectin,
MCP-1, M-CSF, NF-κB,
AP-1, Endothelial-monocyte adhesion
PCR
ELISA
Both RW down-regulated the
expression of adhesion molecules,
ICAM-1, VCAM-1, E-Selectin, MCP-1,
and M-CSF. The results were
statistically significant starting from
the lowest concentration (1 µg/mL)
[14]
Gastric/intestinal function
RW and DRW (GAE 50 µM) Caco-2 To assess the effects of wine on intestinalinflammation IL-6, IL-8, ICAM, COX 2
ELISA
PCR
Only IL-6 was significantly reduced by
RW and DRW (p < 0.05) [15]
PPE from RWE (200, 400,
and 600 µg/mL) HT-29
To evaluate the potential anti-inflammatory action
of RWE enriched in anthocyanins (25.9 mg/g) IL-8, COX-2, NF-κB ELISA
RWE reduced NF-κB, IL-8 and COX-2
production in a
concentration-dependent manner
[16]
PPE from RWE (200, 400,
and 600 µg/mL) HT-29
To elucidate molecular mechanisms underlying
the anti-inflammatory action of a PPE from
Portuguese RWE
JAK/STAT and Nrf2 pathways PCR
RWE significantly reduced the nuclear
levels of phosphorylated STAT1 and
the cellular levels of phosphorylated
JAK1 induced by cytokines,
suppressing the JAK/STAT
inflammatory signaling cascade
[17]
RWE Port Barrel Reserve
prepared from LeNoir grapes
(Vitis aestivalis hybrid)
assayed at 25–100 µg/mL
Human
colon-derived
CCD-18Co
myofibroblasts
cells
To assess the chemopreventive potential of
polyphenolics vs. the inflammation induced by
external stimuli in human colon-derived
CCD-18Co myofibroblasts cells. To assess the
potential involvement of microRNA-126
(miR-126) in the previous mechanisms
NF-κB, ICAM-1, VCAM-1, and
PECAM-1, TNF-α PCR
RWE at 100 µg/mL GAE partially
reversed the pro-inflammatory stimuli
by inducing miR-126 This indicates the
potential role of miR-126 in the
anti-inflammatory properties of
polyphenolics from red wine
[18]
AP-1: activator protein; COX-2: cyclooxigenase-2; ELISA: enzyme-linked immunosorbent assay; GAE: gallic acid equivalent; HMEC: human mammary epithelial cells; HUVEC: human
umbilical vein endothelial cells; ICAM-1: intracellular adhesion molecule; IL: Interleukin; JAK: Janus kinase; STAT: signal transducer and activator of transcription; M-CSF: Monocyte
colony stimulating factor; MCP-1: Monocyte chemoactractant protein-1; miR-126: microRNA-126; NF-κB: nuclear factor-κ light chain enhancer of activated B cells; Nrf2: nuclear factor
erythroid 2-related factor; PCR: polymerase chain reaction; PECAM-1: platelet endothelial cell adhesion molecule; PPE: polyphenol extract; RW: red wine; DRW: dealcoholized red wine;
RWE: red wine extract; TNF-α: tumor necrosis factor α; VCAM-1: vascular cell adhesion molecule; WW: white wine.
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Nicod and co-workers [15] and Nunes and co-workers [16,17] evaluated the effects of wine
polyphenols on inflammatory biomarkers production by CaCo-2 and HT-29 cells, respectively. IL-6,
IL-8, and COX-2 were significantly reduced in a concentration-dependent manner by the wine extracts.
Different mechanisms of action were suggested by the authors [15–17]. Nicod et al. speculated that
microbiota modulation could be involved in the biological effects observed, since the expression of
selected genes encoding for inflammatory mediators (IL-6, IL-8, ICAM, COX 2) was not affected.
Nunes et al. [16,17] showed that wine polyphenols inhibited the NF-κB cascade activation, responsible
for the expression of several inflammatory cytokines, such as IL-8 and COX-2, factors playing an
important role in inflammatory bowel diseases (IBD). A further mechanism could be responsible
for the positive effects of wine: it is the JAK/STAT and Nrf2 (Nuclear Factor erythroid 2-related
factor) signaling pathways activated during inflammatory condition in IBD. These results indicate that
polyphenols from a red wine extract (RWE) could act on multiple targets. According to the authors
and previous studies [19], anthocyanins, the major compounds in RWEs, could be the most important
actor, although the contribution of other polyphenols cannot be excluded.
A different ‘wine’ extract from Lenoir grapes (Vitis aestivalis hybrid) was used by
Angel-Morales et al. [18] to investigate the effects of wine polyphenols on human colon-derived
CCD-18Co myofibroblast cells, which are involved in T-cell function modulation in IBD. In these
pathological conditions several genes encoding for inflammatory mediators (granulocyte-macrophage
colony-stimulating factor, interleukins IL-a, IL-b IL-6, IL-8) and adhesion molecules (intracellular adhesion
molecule (ICAM-1), vascular cell adhesion molecule (VCAM-1)) are overexpressed in fibroblasts, as a
consequence of inflammatory stimuli. This study focused on microRNAs (miRs), and in particular miR-126.
MiRs are a class of endogenous noncoding RNAs, which are involved in post-transcriptional suppression
of genes; miR-126 inhibits the expression of endothelial adhesion molecules reducing inflammation and,
as a consequence, are an alternative target for the anti-inflammatory properties of natural components.
The induction of miR-126 by RWE (at the highest concentration, 100 µg/mL) was the mechanism
by which the extract decreased the expression of VCAM-1. Although the extract was not obtained
from Vitis vinifera, the results suggest the potential role of miR-126 in the beneficial properties of red
wine in a model of intestinal inflammation. For this reason, further studies should be conducted to
investigate if a similar effect can be obtained from Vitis vinifera derivatives, including wine.
In a model of endothelial inflammation, Calabriso et al. [14] showed that endothelial adhesion
molecules (e.g., VCAM-1, ICAM-1, monocyte chemoactractant protein-1 (MCP-1), and E-selectin) were
reduced by the lowest concentration of wine polyphenols tested (1 µg/mL), through a down-regulation
of mRNA levels. This effect was mediated by the inhibition of NF-κB DNA binding activity exerted by
coumaric acid, kaempferol, and resveratrol. Unfortunately, the effects of wine anthocyanins were not
assessed, making a comparison with the other in vitro studies impossible.
3.2. In Vivo Studies
3.2.1. Animal Studies
Table 2 lists the studies performed in animal models aimed to evaluate the effects of wine on
inflammation parameters in different pathological conditions or physiological alterations, including
myocardial infarction, oxidative stress, IBD, gastritis, and metabolic syndrome [20–26].
The animal studies were performed in mice or rats, which are considered a good model for nutritional
and pharmacological trials, also considering the short time required to observe significant changes in
biochemical parameters after treatment. The length of studies varied from 14 days to 6 months.
The moderate consumption of red wine has been associated with a broad spectrum of
health-promoting effects, but the presence of ethanol in different amounts, raised concerns as to
whether or not the polyphenol content can exert positive effects beyond the ethanol toxicity.
The anti-inflammatory activity of red wine was also evaluated in different models of
inflammation/oxidative stress induced by a high fat or fructose diet [21,26], or granuloma [20].
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Table 2. Summary of the collected animal studies used to assess effects of wine on inflammation biomarkers.
Wine/Dosage Animal Model Aim Biomarkers Method Outcomes ShowingSignificant Changes Ref.
Inflammation/Oxidative stress
DRW (350 g/kg) from Spain or
DWW (350 g/kg) for 15 days
before carrageenan-granuloma
induction
No. 21 adult male Sprague Dawley
rats were divided into three groups:
(1) control; (2) a 35% (v/w) DRW
diet; (3) a 35% (v/w) DWW diet
To examine the effects DRW
and DWW on
carrageenan-granuloma
induced inflammation
MDA, COX-2, iNOS
expression, NO, O2-
production by
polymorphonucleate cells
MDA was measured by TBARS
test; free radicals reduction was
measured by ORAC assay; COX2
and iNOS expression was
measured by electrophoresis and
Immunoblotting using
polyclonal antibodies
In both treated groups there
was a decrease of MDA levels
in plasma. In the same groups
PMC showed decreased
superoxide anion production
and increased NO production;
COX-2 was upregulated
(pro-inflammatory effect)
[20]
RW Syrah, Cabernet
Sauvignon, and a blend from
Chile, Brazil, and Argentina,
respectively (alcohol content
12–13%).
Total period: 4 weeks
No. 50 male Wistar rats divided in 5
groups: (1) control diet; (2) high fat
diet + 770–1360 µL of water; (3) high
fat diet + 800–1380 µL of RW with
low antioxidant activity (LOW); (4)
high fat diet + 790–1170 µL of RW
with intermediate antioxidant
activity (MED) or (5) 820–1340 µL of
RW with high antioxidant
activity (HIGH)
To evaluate the effect of wine
on inflammation/oxidative
stress induced by a
high-fat diet
MDA (lipid peroxidation)
Oxidative stress
Antioxidant enzyme
expression: superoxide
dismutase, catalase, and
GPx expression
MDA was measured by TBAR
test; plasmatic antioxidant
activity was measured by ORAC
assay; expression of antioxidant
enzymes was measured
by electrophoresis
Groups supplemented with
wines containing the highest
antioxidant activity (HIGH)
showed the lowest MDA
concentration in liver tissue.
All wines induced antioxidant
enzyme expression
[21]
Myocardial infarction
WW (Grasevina Krauthaker
vintage 2015, 13% alcohol)
5 mL/100 g bw for 4 weeks
38 Sprague Dawley male rats (one
month old) randomized into four
groups: one group including
animals drinking wine and three
reference groups
To evaluate the effect of WW
consumption on granulocyte
and monocytes production
24 h after the surgically
incflicted MI.
This effect is positively
correlated with
tissue regeneration
CD15s, CD11b, and CD44,
MMP-9 expression Flow cytometry
White wine consumption
caused a 3.2-fold (95% CI 1.569
to 3.86, p < 0.0001) increase in
CD44 expression on monocytes
in comparison to the water
drinking controls.
CD44 expression on
granulocytes from wine group
was slightly increased (p =
0.0203) in comparison
to controls
[22]
WW Grasevina Krauthaker
vintage 2015,
13% ethanol)
6 mL/100 g bw
For 4 weeks
24 Sprague Dawley male rats
randomized into 2 groups:
control/water and wine
To investigate the effects of
WW consumption on the
expression of inflammatory
mediators in myocardial
tissue after induced
myocardial ischemia
Three representative
myocardial areas were
identified and analyzed for
inflammatory mediators
(MMP-9, MMP-2, NF-κB,
TG-β1) expression:
infarct/ischemic,
peri-infarct/border zone, and
control/non-ischemic zones
Immunochemistry
MMP-9 were less expressed in
all 3 zones of wine drinking
animals (p < 0.001). MMP-2
expression was significantly
decreased only in
peri-infarctual zones (p < 0.001).
Same pattern of expression was
found for the NF-κB signal
[23]
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Table 2. Cont.
Wine/Dosage Animal Model Aim Biomarkers Method Outcomes ShowingSignificant Changes Ref.
Gastric/Intestinal function
MGE and MWE 500 mg/kg bw
of mice for 14 days
32 female C57BL/6J mice
(8-week-old) randomly divided into
four groups: (1) healthy mice
(control) receiving water; (2) disease
control group; (3–4) treated
colitic mice
To determine the
anti-inflammatory effects of
phytochemical extracts on
DSS-induced colitis in mice
and to investigate
cellular mechanisms.
IL-1β, IL-6, and TNF-α
MPO activity
Mouse cytokine magnetic bead
panel (immunochemical test)
Spectrophotometric measurement
Phytochemicals from MGE or
MWE mitigate ulcerative colitis
via attenuation of pro-
inflammatory cytokine
production, modulation of the
NF-κB pathway,
and MPO activity.
[24]
DRW 5 mL/mouse/day
Total days 14 days, last 4 days
treated with wine (treatment
group) or water (control group)
BALB/c mice (6-week old average
bw18 g) received daily two
intragastric administrations of VacA
To investigate whether RW
influences gastric
inflammation in
VacA-treated mice (toxin
produced by H. pylori)
Alteration of gastric mucosa
Hystological examination of
mucosal alterations and IHC
staining using an antiVacA
monoclonal antibody
The mucosal alterations were
significantly milder in mice
receiving RW vs. control mice.
RW significantly prevented
gastric epithelium damage in
VacA-treated mice
[25]
Metabolic syndrome
Total period: 10 weeks; in the
last 4 weeks animals were
treated with RW. (Malbec)
35 mL/kg bw
No. 40 30-day old male Wistar rats
were assigned to four groups:
1-water group (control), 2- F (10%
fructose in drinking water), 3-F + E
(10%fructose + ethanol 4.5 mL/kg),
4-F + RW (35 mL/kg containing
4.5 mL alcohol).
To evaluate the effects of
moderate consumption of
RW or ethanol on
adiponectin, resistin
expression, and vascular
alterations in FFrs as an
experimental model of MS.
Oxidative stress
Adiponectin and resistin
Adiponectin, resistin, VCAM-1,
and NF-κB protein expression
were evaluated by WB analysis
RW administration to F rats
was able to significantly
decrease insulin resistance,
mesenteric adipose tissue
weight, and SbP compared to F
group. F+RW reduced
adiponectin
expression decreased
[26]
CD: cluster of differentiation; COX-2: cyclooxigenase-2; DRW: dealcoholized red wine; DSS: dextran sulphate sodium; DWW: dealcoholized white wine; E: ethanol; F: fructose; FFrs:
fructose-fed rats; GPx: gluthatione peroxidase; IHC: immunohistochemistry; IL: interleukin; MDA: malondyaldehide; MED: medium; MGE: Muscadine grape extract; MI: myocardial
infarction; MMP: matrix metallopeptidase; MPO: myeloperoxidase; MS: metabolic syndrome; MWE: Muscadine wine extract; NF-κB: nuclear factor-k light chain enhancer of activated B
cells; ORAC: oxygen radical absorbance capacity; PCM: polymorphonucleates; RW: red wine; SbP: systolic blood pressure; TBARS: thiobarbituric acid reactive substances; TNF-α: tumor
necrosis factor α; WB: Western blot; WW: white wine.
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Red wine significantly reduced some parameters of oxidative stress, such as 8-hydroxy-2’-
deoxyguanosine (8-OHdG) and malondialdehyde (MDA), biomarkers of DNA and lipid oxidation,
respectively. In addition, Lopez and co-workers [20], investigating the possible differences between
dealcoholized red (DRW) and white (DWW) wines, showed a greater antioxidant activity of DWR
in vitro and in vivo models. This was probably due to the higher content of polyphenol, ascorbic acid
and sulfites, and to the contribution of wine polyphenols in producing uric acid [10]. According to
Vazquez-Prieto and co-workers [26], the effects of the red wine can be attributed to the polyphenol
content (total phenol content: 2.9 g/L gallic acid equivalents); in particular, catechin (24 mg/L)
and resveratrol (1.1 mg/L) could be involved in the reduction of fat oxidation and the inhibition of
preadipocyte proliferation.
The evaluation of oxidative stress was investigated, as secondary end-point, in several other
studies since it is involved in the development of several disorders, including cardiovascular diseases.
Since data on biological effects of white wine are quite scarce in comparison with red wine,
Rezic-Munizic et al. [22] and Kljucevic et al. [23], evaluated the effects of white wine on inflammatory
biomarkers after myocardial infarction in rats. When compared to controls, wine consumption was
associated with the increase in CD44 (cluster of differentiation 44) expression (0.2-fold, p < 0.0203), which has
a role in fibrous tissue deposition in the healing infarct and in cardiac regeneration. White wine is
relatively rich in non-flavonoid compounds, such as phenolic acids (derivatives of hydroxybenzoic and
hydroxycinnamic acid) and other phenols such as tyrosol, that could mediate the effect on CD44 expression.
A similar study was performed by Kljucevic et al. [23], who found a significant reduced expression of
MMP-2 and MMP-9 (matrix metalloproteinases) in all the representative myocardial areas identified: infarct/
ischemic, peri-infarct/border zone, and control/non-ischemic zones (p < 0.001). This indicates a potential
role of white wine in improving the inflammatory condition associated with cardiovascular impairment,
since MMPs are responsible for the cleavage of several extracellular matrix proteins (activating cytokine
production) and modulate the course and outcome of myocardial infarction. According to the authors’
conclusions, however, this effect is not due to inhibition of the NF-κB pathway mediated by polyphenols.
Unfortunately, neither of the two studies reported the chemical characterization of wine, making it difficult
to establish a correlation between polyphenol content and the biological effects observed.
Finally, as in in vitro models, wine was evaluated in gastric and intestinal inflammation. Ethanol
free RWE (5 mL/day) showed to be effective in reducing epithelial gastric damage induced in
BALB/c mice by purified VacA (a vacuolar toxin produced by H. pylori), but not in influencing gastric
colonization levels, probably because other mechanisms of infection by H. pylori are involved [25].
Considering that gastritis may be caused by other factors, including lifestyle, further studies should
be performed on the effect of wine on gastric mucosa, taking also into account the content of ethanol
(one of the most important gastric inflammation inductor) and phenolic compounds.
In a murine model of colitis, a treatment with a dealcoholized RWE (500 mg/kg bw) from
muscadine grape (Vitis rotundifolia) was able to significantly reduce fecal myeloperoxidase (MPO)
expression (from 10.4 to 5.39 units/mg of tissue); MPO is a pro-oxidative and pro-inflammatory
enzyme produced by neutrophils and monocytes, which accumulates in intestinal mucosa in ulcerative
colitis. The authors speculated that this effect could be mediated by anthocyanins [27], the content of
which was 171.2 mg/g, more than half of the total polyphenol amount present in the extract.
3.2.2. Human Studies
Table 3 describes the studies in humans performed to evaluate the effects of wine on inflammation,
with indication of the models used. Twelve among the 15 trials were performed on healthy subjects.
They were generally designed as randomized, controlled, and cross-over studies where the targets
were the cardiovascular and immune function. To evaluate the effect of “acute” consumption on
inflammation, wine intake ranged from 150 mL to 500 mL/day in a single dose; to simulate the
“regular” intake the period was longer: from 15 days up to 12 months. When reported, total polyphenol
content of wine varied from 1.5 to 3.0 g/L [28–43].
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Table 3. Summary of the collected human trials to assess effects of wine on inflammation biomarkers
Cohort, Sample Size Wine Intake/Duration Aim Biomarkers Biomarkers Measurement Outcomes Ref.
Cardiovascular system
38 healthy adults (wine
consumers 61.44 ± 2.58 y;
non-consumers:
60.73 ± 3.74 y)
Wine intake was assessed by annual
frequency questionnaire
To bear out the association
between the regular
consumption of RW and
some biomarkers of
antioxidant status,
lipid peroxidation,
and inflammation
CRP CRP human instant ELISA
No significant differences in
CRP concentrations between
RW consumers (mean intake =
100 mL) and non-consumers
[28]
87 participants (mean age
50.2 ± 9.6 y)
Daily ingestion of one glass of
RW/day (Cabernet Sauvignon,
150 mL, 15 g of alcohol) or total
abstention. Intervention switch after
3 weeks with no wash-out
To study the acute effect of
RW on the levels of the
inflammatory markers
CRP, Fib
ELISA (CRP); Fib: Clauss’ assay
(based on time for fibrin
clot formation)
The consumption of 150 mL of
RW slightly reduced Fib (3%)
levels but did not reduce CRP
levels in comparison with
total abstention
[29]
10 healthy men (mean
age: 31.4 ± 4.3 y)
On four different days each subject
consumed (with meals): 4 mL/bw of
(1) WW (Robola variety), (2) RW
(Cabernet Sauvignon variety);
(3) ethanol solution (12,5% alcohol);
(4) water
2-week wash out between
treatments were requested
To evaluate the acute effect of
wine consumption on
platelet aggregation (T0–6 h
after intake)
PAF, PAI-I ELISA
At 150 min significant
inhibition of platelet
aggregation by RW (but not
WW) vs. ethanol and water
At 210 min platelet aggregation
by RW vs. water
[30]
12 healthy participants
(mean age 31.3 ± 4.3 y)
In 4 different days each subject
consumed (with meals): 4 mL/bw of
(1) WW (Robola variety), (2) RW
(Cabernet Sauvignon variety);
(3) ethanol solution (12,5% alcohol);
(4) water
2-week wash out between
treatments were requested
To investigate the acute effect
of wine consumption, on
platelet aggregation and
inflammation
PAF biosynthetic
enzymes: Lyso-PAF AT
and PAF-CPT, catabolic
enzyme LpPLA2;
IL-6 levels
Platelet aggregation assay [31];
ELISA
Both RW and WW decreased
enzyme activity compared to
ethanol. The protective effect
of light to moderate wine (RW
and WW) consumption could
partly be explained through
the modulation of PAF levels
by decreasing their
biosynthetic activities.
No differences among
treatments were observed on
IL-6 level reduction
[32]
83 participants (mean age
25.2 ± 1.1 y)
Participants were divided in 5
groups: (1) 264 mL RW; (2) 264 mL
WW; (3) 633 mL of beer; (4) 79 mL
whisky; (5) 264 mL water for 4 weeks
To examine the effect of acute
administration of equivalent
amount of alcohol (30 g) in
different alcoholic beverages,
on endothelial function and
inflammatory processes
(T = 4 h after intake)
IL-6, TNF-α, CRP, Fib,
PAI-1, vWf, tPA ELISA
Only RW and beer significantly
improved endothelial function
and decrease vWf levels, 4 h
after consumption (p < 0.05 for
both) vs. controls. In the same
groups reactive hyperemia was
significantly increased 1 h after
(p < 0.05 for both), while it
returned at baseline at 4 h.
[33]
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Table 3. Cont.
Cohort, Sample Size Wine Intake/Duration Aim Biomarkers Biomarkers Measurement Outcomes Ref.
34 women (mean age
38 ± 8.5 y)
Participants were randomly
assigned to two 4-week periods of 20
g ethanol/d as WW or RW (1 glass
of 100 mL at lunch and at dinner),
with two 4-week washout periods.
To investigate whether low
intake of WW or RW has
differential effects on
inflammatory markers
in women
hs-CRP, ICAM-1,
VCAM-1,
E-selectin,
P-selectin, CD40L, IL-6
hs-CRP: particle-enhanced IN;
ICAM-1, VCAM-1, E-selectin,
P-selectin, CD40L: ELISA
Both RW and WW reduced
hs-CRP, ICAM-1, CD40L, IL-6
levels (p < 0.01) and CAMs
expression by mononuclear
cells (greater effect for RW).
VCAM-1 and E-selectin
decreased (p < 0.01) only in
RW group.
[34]
48 subjects (mean age
43.6 ± 10.6 y)
Participants were randomly
assigned to two 4-week periods of
Sicilian RW consumption (250 mL/d
Nero d’Avola or 250 mL/d Etna
Torrepalino-Solicchiata at meals),
with 4-week washout periods.
To evaluate the effect of
moderate RW consumption
on some inflammatory
biomarkers associated with
cardiovascular risk factor
Plasma CRP, TGF-β1,
D-Dimer, Factor VII, PAI
Ag, tPA Ag, Fib, oxidized
LDL Ab, TPAC
ELISA;
ORAC assay for
antioxidant activity
Both RW reduced Fib, factor
VII, plasma CRP and oxidized
LDL levels, while TGF-β1, tPA,
PAI, and TPAC were
significantly increased.
[35]
40 healthy adult men
(mean age: 37.6 ± 7.4 y)
Participants consumed two 160 mL
glasses of RW (Merlot) or 100 mL gin
(both 30 g of ethanol) for 28 days
with 15 days wash out
between treatments
To evaluate the effects of
wine and gin on
inflammatory biomarkers of
atherosclerosis
LFA-1, VLA-4, MCP-1,
VCAM-1, ICAM-1,
IL-1α, hs-CRP and Fib
ELISA
Both gin and RW reduced
plasma Fib and IL-1α levels.
Only RW reduced serum
concentrations of hs-CRP
(−21%), VCAM-1 (−17%) and
ICAM-1 (−9%).
[36]
20 healthy adults
(mean age 31.1 ± 0.8 y)
All participants smoked 3 cigarettes;
n. 10 subjects consumed 1 h before
smoking an amount of RW (Chateau
Haut-Pontet) aiming to reach 0.075%
blood alcohol content.
To evaluate whether RW
consumption counteracts the
adverse vascular effects of
acute cigarette smoking.
IL-6, TNF-α, IL-1b
expression, CD14,
leukocytes
ELISA
Wine significantly reduced
endothelial, platelet-,
monocyte-, and
leukocyte-derived
microparticles (p < 0.001 each)
and mRNA expression of IL-6,
TNF-α, and IL-1b in monocytes
vs. only smokers
[37]
13 subjects with CAD
(mean age 59.1 ± 7.0)
Participants received 4 mL/kg bw (2
to 3 glasses, corresponding to 0.52 g
alcohol/kg bw) of RW (Stoneleigh
Marlborough Pinot Noir) or WW
(Jackson Estate Marlborough
Sauvignon Blanc) at meals, with
1-week wash out between
interventions.
Three months after wine study,
subjects received a non-alcoholic
beverage 4 mL/kg bw at meals
To compare the acute effects
of ingestion of RW and WW
(T = 6 h after intake) on
markers of inflammation in
men with CAD.
IL-6, VCAM-1, ICAM-1 ELISA
Acute RW and WW intake
significantly increase plasma
levels of IL-6 vs.
non-alcoholic beverages
[38]
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Table 3. Cont.
Cohort, Sample Size Wine Intake/Duration Aim Biomarkers Biomarkers Measurement Outcomes Ref.
Immune function
27 healthy subjects (mean
age 28 ± 6.3)
The study was performed in
two parts:
1—Bolus study
Participants received: 200 mL RW
(Marienthaler Spatburgunder
Klostergarten, 12% ethanol) (No. 9)
or 200 mL DRW (Marienthaler
Spatburgunder Klostergarten)
(No. 9) or 200 mL water (No. 9)
2—Dietary intervention study
(6-week)
Subjects ingested 200 mL RW (n.27),
175 mL DRW (n. 26), water 200 mL
(n. 25) 1 h after dinner
To evaluate effect of acute
(T = 360 min after intake) and
regular consumption
(6 weeks) of wine on
immunological parameters
T cell apoptosis,
granulocytes, and
monocytes phagocytosis
Annexin V fluorescein
isothocyanate
(FICT)/DNA-labeling
flow-cytometry (Phagotest)
Only acute intake of RW
decreased T cell apoptosis
(p = 0.006 vs. p = 0.024
of controls).
No other significant changes
were observed among groups
[39]
24 healthy non-smoking
men (mean age
30.6 ± 1.4 y)
Subjects were randomly assigned to
consume for 15 days 500 mL/day of
RW (Lemberger, 12% ETOH v/v),
DRW, RGJ (var Lemberger), and
ETOH (12% ethanol v/v), with a
wash-out period of 1-week between
each experimental treatment
To investigate: (1) whether
daily consumption of a
moderate volume of RW
modulates immune functions
in healthy men in 2 weeks;
(2) polyphenols in RW induce
changes in immune functions
vs. a 12% ETOH beverage.
Phagocytic activity of
neutrophils and
monocytes, production of
TNFα, IL-2 and IL-4,
TGF-β, expression of
TNF-α mRNA,
lymphocyte proliferation,
lytic activity of NK cells,
and percentage of
apoptotic lymphocytes.
By flow-cytometry:
lytic activity, phagocytosis and
apoptosis
by immunoassay:
lymphocyte proliferation and
cytokine secretion.
Consumption of a moderate
volume of alcohol with RW
and with a 12% ETOH, or RGJ
had no effect on immune
functions in healthy males.
[40]
Type 2 diabetes
24 T2D patients
(mean age: 59.3 ± 1.1 y)
and 22 healthy volunteers
(mean age:54.1 ± 1.4 y)
Three study periods, each of 4-week
(with no wash out): (1) RW
(Shiraz Cabernet, 13% alcohol)
(women: 230 mL/day men:
300 mL/day) at dinner; (2) DRW
(Shiraz Cabernet (women:
230 mL/day men: 300 mL/day) at
dinner; (3) Water
To examine the effects of RW
on plasmatic SPMs, involved
in promoting homeostasis
after flogistic events
SPMs included:
18-HEPE, 17-HDHA,
14-HDHA, resolvins,
and protectins
LC/MS-MS
RW did not differentially affect
any of the SPMs measured in
T2D patients when compared
with DRW or water.
[41]
Type 2 diabetes
115 subjects with T2D
with recent history of MI
(mean age 35.5 ± 5.5 y)
Patients received 118 mL/day RW
(Barbera, 11 g alcohol) with meals or
not alcoholic beverages for
12 months
To examine the effects of
moderate RW intake, with
meals, on cardiac functions
and inflammatory cytokine
levels in T2D patients
after MI
CRP, TNF-α, IL-6, IL-18
Highly sensitive, quantitative
sandwich enzyme assay
CRP: IN
RW in the intervention group
significantly reduced
pro-inflammatory cytokines
CRP, TNF-α, IL-6, IL-8 vs.
control group
[42]
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Table 3. Cont.
Cohort, Sample Size Wine Intake/Duration Aim Biomarkers Biomarkers Measurement Outcomes Ref.
801 participants
(68.5 ± 7.2 years)
Subjects were classified as
non-consumers (no consumption of
alcohol-containing beverages
including wine); moderate
consumers and high consumers
(men: ethanol intake >20 g/d;
women: ethanol intake >10 g/d).
To investigate the association
between wine consumption
and endothelial dysfunction
and low-grade inflammation
Endothelial dysfunction
was evaluated using
Z-scores (higher scores
indicate worse function)
for: vWf, sE-selectin,
sTM, sVCAM-1 and
sICAM-1, low-grade
inflammation: CRP, SAA,
IL-6, IL-8, TNF-α and
sICAM-1
Multiarray detection system
based on ECL technology
vWf: ELISA
Wine consumption was
associated with a lower
endothelial dysfunction vs.
wine abstention but not vs.
alcohol intake
[43]
Ab: antibody; Ag: antigen; CAD: coronary artery disease; CAMs: cellular adhesion molecule; CD: clusters of differentiation; CRP: C-reactive protein; DRW: dealcoholized red wine; ECL:
electrochemiluminescence; ELISA: enzyme-linked immunosorbent assay; Fib: Fibrinogen; FICT: fluorescent immunochromatographic strip test; HDHA: hydroxydocosahexaenoic acid;
HEPE: hydroxyeicosapentaenoic acid; hs-CRP: high-sensitivity C-reactive protein; ICAM: intercellular adhesion molecule; IL: interleukin; IN: immunonephelometry; LC-MS/MS: liquid
chromatography-tandem mass spectrometry; LDL: low density lipoprotein; LFA: lymphocyte function-associated; LpPLA2: lipoprotein-associated phospholipase A2; Lyso-PAF AT:
lyso-platelet-activating factor acetyltransferase; MCP: monocyte chemoattractant protein; MI: myocardial infarction; mRNA: messenger RNA; NK: natural killer cell; ORAC: oxygen
radicals absorbance capacity; PAF CPT: platelet-activating factor-cholinephosphotransferase; PAF: platelet-activating factor; PAI: plasminogen activator inhibitor; RGJ: red grape juice; RW:
red wine; SAA: serum amyloid A; sE-selectin: soluble E-selectin; sICAM: soluble intercellular adhesion molecule; SPM: specialized pro-resolving mediators of inflammation; sTM: soluble
thrombomodulin; sVCAM: soluble Vascular cell adhesion protein; T2D: type 2 diabetes mellitus; TGF-β: transforming growth factor-beta; TNF-α: tumor necrosis factor alpha; tPA: tissue
plasminogen activator; TPAC: total plasma antioxidant capacity; VCAM: vascular cell adhesion protein; VLA: very late antigen; vWf: von Willebrand factor; WW: white wine.
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Among inflammation parameters investigated, C-reactive protein (CRP) was one of the most
considered, since it has been identified by several authors as a significant predictor of cardiovascular
events [44]. Acute red wine intake (fasting or at meals) was not associated with significant C-reactive
protein reduction, as observed by Cuervo et al. [28], and Retterstol et al. [29]. This could be due to
different factors; among the others:
1. The duration of the study, which could be too short to observe a significant
change in inflammatory parameters in healthy subjects having physiological CRP levels
(0.11–0.55 mg/dL) [28]. The study by Marfella et al. [42], seemed to support this hypothesis.
Indeed, T2D patients, with a myocardial infarction history, consuming 118 mL wine/day in
the previous 12 years showed CRP levels significantly lower when compared to abstainers
(p < 0.01) [42];
2. The amount of wine consumed (100–150 mL/day, 15 g ethanol) was lower when compared to
studies where a CRP reduction was observed (>200 mL, 20 g ethanol) [36].
Fibrinogen and other factors involved in platelet aggregation (e.g., platelet-activating factor—PAF;
von Willebrand factor—vWf; plasminogen activator inhibitor—PAI-I; plasminogen activator
inhibitor/tissue plasminogen activator—PAI/tPA ratio) appear to be affected by both acute and regular
intake of both red and white wine. The acute effect of ethanol on platelet aggregation is controversial,
as both inhibition and stimulation effects have been reported [45,46]. In the studies described in
this review, red wine, but not ethanol, water or white wine alone, reduced platelet aggregation
within 3.5 h, suggesting an additional positive effect of polyphenols of red wine. Two studies
reported an additional effect on circulating endothelial adhesion molecules ICAM-1 and VCAM-1,
after red wine consumption (160–280 mL/day) [36,43]. If confirmed, these effects could explain the
reduced vWf levels observed in moderate wine diabetic consumers, since hyperglycemia stimulates
platelet aggregation [43]. Taking into account the number of studies collected and the low number
of trial participants, however, the effects of wine on aggregation has to be investigated in further
well-designed studies.
As regards other inflammatory parameters, such as interleukins and their gene expression,
some discrepancies have been observed in the literature. Schwarz et al. [37] and Sacanella et al. [34]
observed a significant reduction of IL-6 levels and its expression, after acute or regular wine intake
(4 weeks 200 mL red wine + 4 weeks 200 mL white wine) in healthy subjects. On the other hand,
no effects on IL-6 were found by Argyrou et al. [32] and Tousolis et al. [33] after acute consumption of
wine. This result was confirmed by Williams et al. [38], who measured an IL-6 increase in patients with
CAD (coronary artery disease). It is possible that in acute consumption, the alcohol-mediated oxidative
stress in the liver may be involved in the cytokines production increase [47]; on the other hand,
longer term wine consumption could enable the wine phenolic fraction to counteract this imbalance.
In fact, according to in vitro studies, flavonoids in wine suppress the synthesis of proinflammatory
cytokines and chemokines (such as TNF-α, IL-1b, IL-6, IL-8, and MCP-1, von Willebrand plasma
levels), mainly via NF-κB pathway modulation [45].
Neither regular (500 mL/day for 2 weeks) nor acute (200 mL/one dose) consumption of red wine
were associated with a positive effect on inflammatory biomarkers associated with immunological
responses such as neutrophils and monocytes phagocytic activity and T cell apoptosis in healthy
subjects [39,40], confirming that NF-κB is a possible mediator of the wine protective effects.
Table 4 summarizes, for each physiological system, the results of in vitro, animal, and human
studies reviewed in this paper [12–16,18–24,28–30,32–34,37–43].
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Table 4. Summary of in vitro, animal, and human studies reviewed.
Area Wine Amount Results Ref.
In
vi
tr
o
st
ud
ie
s
Cardiovascular 1–25 µmol/L GAE RW ↓endothelial adhesionmolecules [14]
Intestinal (Caco2) 8.51 µg/mL GAE RW ↓IL-6 [15]
Intestinal (H29) 100–600 µg/mL GAE RW ↓IL-8 and ↓COX2 [16,17]
Intestinal
(Colon-derived CCD-18Co
myofibroblast cells)
25–100 µg/mL GAE RW ↓VCAM-1 [18]
Area Wine amount Results Ref.
A
ni
m
al
st
ud
ie
s Cardiovascular (rats)
50 mL/kg bw
WW for 4 weeks
↑CD44 expression;
↓MMP-9 expression [22,23]
35 mL/Kg bw
RW for 4 weeks
↓adiponectin, ↓resistin,
↓VCAM-1 and ↓plasmatic
antioxidant activity
[26]
Gastric/Intestinal (mice) 250 mL/kg bw/day
RW 4 days
↓epithelial gastric damage [25]
↓MPO levels [24]
Inflammation (rats)
28 mL/Kg bw
DRW and DWW for 15 day
↓Oxidative stress (RW)
↓MDA (RW and WW) [20]
3.6 mL/Kg bw RW 4 weeks ↓MDA [21]
H
um
an
st
ud
ie
s
*
Cardiovascular (Healthy subjects)
1.4 mL/kg bw RW 12 months ↓MDA [28]
2.1 mL/kg bw RW 3 weeks ↓Fib [29]
4 mL/kg bw day RW and WW,
single dose ↓PAF, ↓E-selectin, ↓ICAM,
↓TNF-α, ↓IL-6, ↓IL-8, ↓CRP
[30,32,33]
2.9 mL/kg bw day RW and WW
for 4 weeks each [34]
RW aiming to reach 0.075%
blood alcohol in occasional
smokers
↓IL-6, ↓TNF-α, ↓IL-1b [37]
Cardiovascular (CAD patients) 4 mL/kg bw, single dose ↑IL-6 [38]
Type 2 diabetes
>0–<20 g/day
0–<2.9 mL/kg bw ↓inflammatory parameters [43]
1.69 mL/kg bw RW for 12
months ↓inflammatory parameters [42]
3.8 mL/kg bw
RW or DRW for 4 weeks each No effects [41]
Immune function 2.50 mL/kg bw RW single dose;7.14 mL/kg bw RW for 2 weeks No effects [39,40]
* To compare wine amount intake in human studies, a 70 kg average weigh was used. CD: clusters of differentiation;
COX-2: cyclooxigenase-2; CRP: C-reactive protein; DRW: dealcoholized red wine; DWW: dealcoholized white
wine; Fib: Fibrinogen; GAE: gallic acid equivalent; ICAM: intercellular adhesion molecule; IL: interleukin; MDA:
malondyaldehide; MMP: matrix metallopeptidase; MPO: myeloperoxidase; PAF: platelet-activating factor; RW: red
wine; TNF-α: tumor necrosis factor α; VCAM: vascular cell adhesion protein; WW: white wine.
In in vitro models, wine extracts were generally used in an amount aimed to mimic the in vivo
polyphenol concentrations observed in the colon [48]. The reduction of inflammatory cytokines
(e.g., IL-6, IL-8, COX-2, and VCAM-1) was observed using red wine polyphenol concentrations in the
range of 0.17–600 µg/mL. These effects seem to be mediated by the inhibition of NF-κB DNA binding
activity, while other pathways seem to be less involved (i.e., AP-1). According to the authors and
previous studies [19] anthocyanins, which are among the most abundant compounds in RWEs, could be
the main responsible for the biological effects observed, although the contribution of other polyphenols,
including procyanidins, cannot be excluded. Moreover, coumaric acid, kaempferol, and resveratrol
showed a lower concentration but a specific higher activity in reducing the inflammatory parameters.
In animal studies, MDA and 8-OHdG, markers of oxidative stress, were significantly reduced by
wine. It should be noticed that in most studies, dealcoholized extracts were used, so that only the effect
of wine polyphenols was evaluated. In gastric/intestinal areas, animal studies showed promising
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positive effects for wine (50–250 mL/kg bw rats or mice) in reducing cytokine production and gastritis
severity associated with H. pylori infection. This effect has to be confirmed, however, in human studies.
4. Conclusions
The purpose of this review was to collect and discuss the experimental approaches and the
scientific evidences of in vitro and in vivo studies aimed to evaluate the relationship between wine
consumption and inflammation. Even though moderate wine consumption has been associated with
lower risk for cardiovascular diseases, a great heterogeneity characterizes the studies performed to
establish a correlation among beneficial effects of wine consumption: wine typology, composition
(when reported), biomarkers measured, length and amount of consumption, together with the use of
appropriate controls make difficult a suitable comparison.
In humans, inflammatory parameters associated with platelet aggregation seem to be affected by
moderate wine intake, while contradictory results were obtained for some inflammation biomarkers
(e.g., CRP and IL-6). Conversely, no significant effects were measured in inflammatory responses
associated with immune function. For this reason, further studies (including in vitro models),
evaluating wine effects on biomarkers of immune response, should be designed. Integration of
in vitro studies with animal and human trials could lead to a better wine effects evaluation and
comprehension of the most plausible mechanisms of action.
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